Clinical Trial: Doxycycline: A Novel Treatment for Cardiorenal Syndrome

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Doxycycline: A Novel Treatment for Cardiorenal Syndrome

Brief Summary: The goal of this trial is to evaluate whether subantimicrobial-dose of doxycycline (20mgBID) will affect serum and urine biomarkers of fibrosis in patients with pre-dialysis chronic kidney disease.